Keebeck Wealth Management »

Relmada Therapeutics shares owned by Keebeck Wealth Management

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Keebeck Wealth Management from 13F filings

Historical chart of Keebeck Wealth Management investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Keebeck Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Keebeck Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $91k 13k 6.96

More positions owned by Keebeck Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Goldman Sachs Etf Tr Marketbeta Us Eq (GSUS)
Vanguard World Inf Tech Etf (VGT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Goldman Sachs Etf Tr Access Us Agrat (GCOR)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Microsoft Corporation (MSFT)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr National Mun Etf (MUB)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Ishares Tr S&p 100 Etf (OEF)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Core Msci Emkt (IEMG)
Wisdomtree Tr Floatng Rat Trea (USFR)

View all positions for Keebeck Wealth Management

Top funds holding Relmada Therapeutics

Henderson Group
Squadron Capital Management
VR Adviser
Adage Capital Partners GP
OrbiMed Advisors
Marshall Wace
Millennium Management
Vanguard Capital Management
RA Capital Management
Ikarian Capital
Driehaus Capital Management
Ameriprise Financial
Polar Capital Holdings
Susquehanna International
BlackRock

View all funds holding Relmada Therapeutics